As shown in Figures 3A–C, tumor-bearing mice receiving OLT1177 exhibited significantly less constitutive STAT3 (p<0.05) and pSTAT3(Y705) (p<0.05) in the bone marrow compared to vehicle-treated mice. Here, STAT3 is linked to neoplasm.